Canopy Growth (CGC) Other Working Capital Changes (2019 - 2025)
Canopy Growth's (CGC) quarterly Other Working Capital Changes came in at -$1.7 million in Q4 2025, up 52.34% year-on-year from -$1.1 million in Q4 2024, and down 181.84% quarter-over-quarter from $2.1 million in Q3 2025.
Canopy Growth (CGC) Other Working Capital Changes (2019 - 2025) Analysis & Trends
Canopy Growth has disclosed Other Working Capital Changes across 7 years of filings, most recently posting -$1.7 million for Q4 2025.
- Other Working Capital Changes for Q4 2025 came in at -$1.7 million, up 52.34% year-over-year; the trailing twelve-month figure through Dec 2025 was -$2.1 million (down 222.62% YoY), and the FY2025 annual result was -$4.0 million, down 320.74% from the prior year.
- Other Working Capital Changes came in at -$1.7 million for Q4 2025 at Canopy Growth, down from $2.1 million in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $9.0 million in Q4 2021 to a low of -$38.9 million in Q3 2021.
- The 5-year median for Other Working Capital Changes is $461709.0 (2023), against an average of -$1.7 million.
- Across the five-year window, Other Working Capital Changes tumbled 1263.15% in 2023 and jumped 1323.57% in 2025, its largest moves.
- Canopy Growth's Other Working Capital Changes stood at $9.0 million in 2021, then sank by 170.07% to -$6.3 million in 2022, then soared by 106.88% to $435579.6 in 2023, then sank by 922.05% to -$3.6 million in 2024, then jumped by 52.34% to -$1.7 million in 2025.
- The last three Other Working Capital Changes figures came in at -$1.7 million (Q4 2025), $2.1 million (Q3 2025), and $1.9 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Canopy Growth | 11.38 Mn | -137.31 Mn | 15.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.71 Mn |
| Dec 31, 2025 | -1.71 Mn |
| Sep 30, 2025 | 2.09 Mn |
| Sep 30, 2025 | 2.09 Mn |
| Jun 30, 2025 | 1.93 Mn |
| Jun 30, 2025 | 1.93 Mn |
| Mar 31, 2025 | -4.43 Mn |
| Mar 31, 2025 | -4.43 Mn |
| Dec 31, 2024 | -3.58 Mn |
| Dec 31, 2024 | -3.58 Mn |
| Sep 30, 2024 | 4.00 Mn |
| Sep 30, 2024 | 4.00 Mn |
| Jun 30, 2024 | 135,261.00 |
| Jun 30, 2024 | 135,261.00 |
| Mar 31, 2024 | 1.18 Mn |
| Mar 31, 2024 | 1.18 Mn |
| Dec 31, 2023 | 435,579.57 |
| Dec 31, 2023 | 435,579.57 |
| Sep 30, 2023 | 487,838.53 |
| Sep 30, 2023 | 487,838.53 |